Anika Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 29.6M | 30.6M | 27.8M | 28.2M | 26.2M | -1.3M | 38.8M | 30.7M |
| Cost of Goods Sold | 10.6M | 11.4M | 12.2M | 13.9M | 11.5M | -23.9M | 37.3M | 10.2M |
| Gross Profit | 19.0M | 19.2M | 15.6M | 14.4M | 14.7M | 22.6M | 1.4M | 20.5M |
| R&D Expenses | 6.7M | 6.5M | 6.9M | 6.3M | 6.1M | 2.7M | 7.2M | 6.7M |
| Operating Expenses | 24.5M | 18.5M | 18.8M | 18.5M | 19.0M | -5.3M | 29.5M | 22.3M |
| Operating Income | -5.5M | 646K | -3.2M | -4.2M | -4.3M | 27.8M | -28.0M | -1.8M |
| Other Income / Gains | 667K | 118K | 997K | 214K | 415K | 744K | 406K | 595K |
| Net Income | -5.1M | 292K | -2.3M | -4.0M | -4.9M | -21.9M | -29.9M | -88K |
| EPS (Diluted) | -0.37 | 0.021 | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.006 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.642 | 0.626 | 0.56 | 0.509 | 0.561 | -17.492 | 0.037 | 0.667 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 17.8M | 12.1M | 11.9M | 12.2M | 12.9M | -4.9M | 19.1M | 15.6M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | -3.1M | 3.1M | 0 |
| Cost And Expenses | 35.1M | 30.0M | 31.1M | 32.4M | 30.5M | -29.1M | 66.8M | 32.5M |
| Interest Income | 0 | 0 | 0 | 214K | 0 | 0 | 406K | 595K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 1.4M | 1.3M | 1.4M | 1.5M | 1.6M | 1.8M | 2.2M | 2.1M |
| Ebitda | -3.4M | 2.1M | -836K | -2.5M | -2.3M | 26.5M | -25.4M | 843K |
| Ebitdaratio | -0.115 | 0.068 | -0.03 | -0.087 | -0.087 | -20.565 | -0.656 | 0.027 |
| Operating Income Ratio | -0.185 | 0.021 | -0.116 | -0.148 | -0.164 | -21.564 | -0.723 | -0.059 |
| Income Before Tax | -4.8M | 764K | -2.2M | -4.0M | -3.9M | 28.6M | -27.6M | -1.2M |
| Income Before Tax Ratio | -0.163 | 0.025 | -0.08 | -0.141 | -0.148 | -22.141 | -0.712 | -0.04 |
| Income Tax Expense | 235K | -1.0M | 939K | 681K | 89K | 2.9M | 2.3M | 1.3M |
| Net Income Ratio | -0.171 | 0.01 | -0.084 | -0.141 | -0.186 | 16.95 | -0.772 | -0.003 |
| Epsdiluted | -0.37 | 0.02 | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.006 |
| Weighted Average Shs Out | 13.5M | 14.3M | 14.4M | 14.4M | 14.3M | 14.6M | 14.8M | 14.8M |
| Weighted Average Shs Out Dil | 13.5M | 14.7M | 14.4M | 14.4M | 14.3M | 14.7M | 14.8M | 14.8M |